_id

6910585dccc777a4e85d56e4

Ticker

CYCN

Name

Cyclerion Therapeutics Inc

Exchange

NASDAQ

Address

245 First Street, Riverview II, Cambridge, MA, United States, 02142

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.cyclerion.com

Description

Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases serious diseases with novel sGC stimulators in both the central nervous system (CNS) and the periphery. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to treat cardiovascular diseases; and Praliciguat, a systemic sGC stimulator for the treatment of rare kidney disease. It has a license agreement with Akebia to develop, manufacture, medical affair, and commercializes Praliciguat and other related products. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Last Close

1.68

Volume

25790

Current Price

1.51

Change

-10.119047619047615

Last Updated

2025-11-29T12:04:42.475Z

Image

data:image/webp;base64,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

Ipo Date

2019-04-02T00:00:00.000Z

Market Cap

6013815

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.984

Sentiment Sources

1

Rating

5

Target Price

4

Strong Buy

1

Buy

0

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

875000

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

1881000

Operating Income

-1006000

Interest Expense

-

Pretax Income

-976000

Net Income

-976000

Eps

-0.30263565891472866

Dividends Per Share

-

Shares Outstanding

3806212

Income Tax Expense

-

EBITDA

-976000

Operating Margin

-114.97142857142858

Total Other Income Expense Net

30000

Cash

4568000

Short Term Investments

-

Receivables

100000

Inventories

-

Total Current Assets

5065000

Property Plant Equipment

-

Total Assets

10415000

Payables

480000

Short Term Debt

-

Long Term Debt

-

Total Liabilities

877000

Equity

9538000

Depreciation

-

Change In Working Capital

594000

Cash From Operations

-264000

Capital Expenditures

0

Cash From Investing

-

Cash From Financing

1826000

Net Change In Cash

1562000

PE

-

PB

0.5105630111134409

ROE

-10.232753197735374

ROA

-9.371099375900144

FCF

-264000

Fcf Percent

-0.3017142857142857

Piotroski FScore

1

Health Score

34

Deep Value Investing Score

6

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

4.8

Garp Investing Score

4.5

Growth Investing Score

3

Momentum Investing Score

3.5

Net Net Investing Score

3.5

Quality Investing Score

2.5

Value Investing Score

6.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

875000

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

1881000

Quarters > 0 > income Statement > operating Income

-1006000

Quarters > 0 > income Statement > interest Expense

-

Quarters > 0 > income Statement > pretax Income

-976000

Quarters > 0 > income Statement > net Income

-976000

Quarters > 0 > income Statement > eps

-0.30263565891472866

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

3225000

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-976000

Quarters > 0 > income Statement > operating Margin

-114.97142857142858

Quarters > 0 > income Statement > total Other Income Expense Net

30000

Quarters > 0 > balance Sheet > cash

4568000

Quarters > 0 > balance Sheet > short Term Investments

-

Quarters > 0 > balance Sheet > receivables

100000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

5065000

Quarters > 0 > balance Sheet > property Plant Equipment

-

Quarters > 0 > balance Sheet > total Assets

10415000

Quarters > 0 > balance Sheet > payables

480000

Quarters > 0 > balance Sheet > short Term Debt

-

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

877000

Quarters > 0 > balance Sheet > equity

9538000

Quarters > 0 > cash Flow > net Income

-976000

Quarters > 0 > cash Flow > depreciation

-

Quarters > 0 > cash Flow > change In Working Capital

594000

Quarters > 0 > cash Flow > cash From Operations

-264000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-

Quarters > 0 > cash Flow > cash From Financing

1826000

Quarters > 0 > cash Flow > net Change In Cash

1562000

Quarters > 0 > ratios > PE

-0.30263565891472866

Quarters > 0 > ratios > PB

0.5105630111134409

Quarters > 0 > ratios > ROE

-10.232753197735374

Quarters > 0 > ratios > ROA

-9.371099375900144

Quarters > 0 > ratios > FCF

-264000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-0.3017142857142857

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

93000

Quarters > 1 > income Statement > cost Of Revenue

-

Quarters > 1 > income Statement > gross Profit

93000

Quarters > 1 > income Statement > operating Expenses

1765000

Quarters > 1 > income Statement > operating Income

-1672000

Quarters > 1 > income Statement > interest Expense

-

Quarters > 1 > income Statement > pretax Income

-324000

Quarters > 1 > income Statement > net Income

-324000

Quarters > 1 > income Statement > eps

-0.10550309345490068

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

3071000

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-1672000

Quarters > 1 > income Statement > operating Margin

-1797.8494623655913

Quarters > 1 > income Statement > total Other Income Expense Net

1348000

Quarters > 1 > balance Sheet > cash

3006000

Quarters > 1 > balance Sheet > short Term Investments

-

Quarters > 1 > balance Sheet > receivables

525000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

4020000

Quarters > 1 > balance Sheet > property Plant Equipment

-

Quarters > 1 > balance Sheet > total Assets

9370000

Quarters > 1 > balance Sheet > payables

462000

Quarters > 1 > balance Sheet > short Term Debt

-

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

800000

Quarters > 1 > balance Sheet > equity

8570000

Quarters > 1 > cash Flow > net Income

-324000

Quarters > 1 > cash Flow > depreciation

-

Quarters > 1 > cash Flow > change In Working Capital

-293000

Quarters > 1 > cash Flow > cash From Operations

-503000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

-

Quarters > 1 > cash Flow > cash From Financing

-130000

Quarters > 1 > cash Flow > net Change In Cash

-633000

Quarters > 1 > ratios > PE

-0.10550309345490068

Quarters > 1 > ratios > PB

0.541098016336056

Quarters > 1 > ratios > ROE

-3.780630105017503

Quarters > 1 > ratios > ROA

-3.4578441835645677

Quarters > 1 > ratios > FCF

-503000

Quarters > 1 > ratios > Piotroski FScore

0

Quarters > 1 > ratios > fcf Percent

-5.408602150537634

Quarters > 1 > health Score

33

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

81000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

81000

Quarters > 2 > income Statement > operating Expenses

1538000

Quarters > 2 > income Statement > operating Income

-1457000

Quarters > 2 > income Statement > interest Expense

-

Quarters > 2 > income Statement > pretax Income

-1429000

Quarters > 2 > income Statement > net Income

-1429000

Quarters > 2 > income Statement > eps

-0.559076682316119

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

2556000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-1457000

Quarters > 2 > income Statement > operating Margin

-1798.7654320987656

Quarters > 2 > income Statement > total Other Income Expense Net

28000

Quarters > 2 > balance Sheet > cash

3639000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

581000

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

4497000

Quarters > 2 > balance Sheet > property Plant Equipment

-

Quarters > 2 > balance Sheet > total Assets

9847000

Quarters > 2 > balance Sheet > payables

483000

Quarters > 2 > balance Sheet > short Term Debt

-

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

1067000

Quarters > 2 > balance Sheet > equity

8780000

Quarters > 2 > cash Flow > net Income

-1429000

Quarters > 2 > cash Flow > depreciation

-

Quarters > 2 > cash Flow > change In Working Capital

347000

Quarters > 2 > cash Flow > cash From Operations

-968000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

-

Quarters > 2 > cash Flow > cash From Financing

1375000

Quarters > 2 > cash Flow > net Change In Cash

407000

Quarters > 2 > ratios > PE

-0.559076682316119

Quarters > 2 > ratios > PB

0.43958542141230067

Quarters > 2 > ratios > ROE

-16.275626423690206

Quarters > 2 > ratios > ROA

-14.512034122067636

Quarters > 2 > ratios > FCF

-968000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-11.950617283950617

Quarters > 2 > health Score

34

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

1806000

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

1806000

Quarters > 3 > income Statement > operating Expenses

1304000

Quarters > 3 > income Statement > operating Income

502000

Quarters > 3 > income Statement > interest Expense

-

Quarters > 3 > income Statement > pretax Income

530000

Quarters > 3 > income Statement > net Income

530000

Quarters > 3 > income Statement > eps

0.208176055668634

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

2545922

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

502000

Quarters > 3 > income Statement > operating Margin

27.796234772978963

Quarters > 3 > income Statement > total Other Income Expense Net

28000

Quarters > 3 > balance Sheet > cash

3232000

Quarters > 3 > balance Sheet > short Term Investments

-

Quarters > 3 > balance Sheet > receivables

556000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

4225000

Quarters > 3 > balance Sheet > property Plant Equipment

0

Quarters > 3 > balance Sheet > total Assets

9575000

Quarters > 3 > balance Sheet > payables

390000

Quarters > 3 > balance Sheet > short Term Debt

-

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

725000

Quarters > 3 > balance Sheet > equity

8850000

Quarters > 3 > cash Flow > net Income

530000

Quarters > 3 > cash Flow > depreciation

-

Quarters > 3 > cash Flow > change In Working Capital

-292000

Quarters > 3 > cash Flow > cash From Operations

360000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

-

Quarters > 3 > cash Flow > cash From Financing

0

Quarters > 3 > cash Flow > net Change In Cash

360000

Quarters > 3 > ratios > PE

0.208176055668634

Quarters > 3 > ratios > PB

0.4343889514124294

Quarters > 3 > ratios > ROE

5.988700564971752

Quarters > 3 > ratios > ROA

5.535248041775457

Quarters > 3 > ratios > FCF

360000

Quarters > 3 > ratios > Piotroski FScore

3

Quarters > 3 > ratios > fcf Percent

0.19933554817275748

Quarters > 3 > health Score

77

Valuation > metrics > PE

-0.30263565891472866

Valuation > metrics > PB

0.5105630111134409

Valuation > final Score

70

Valuation > verdict

48.9% Undervalued

Profitability > metrics > ROE

-10.232753197735374

Profitability > metrics > ROA

-19.26949654491609

Profitability > metrics > Net Margin

-1.1154285714285714

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.09194799748374921

Risk > final Score

80

Risk > verdict

Low

Liquidity > metrics > Current Ratio

10.552083333333334

Liquidity > metrics > Quick Ratio

10.552083333333334

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

90

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

72

Prev Risks > 0

55

Prev Risks > 1

-148

Prev Risks > 2

100

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:22:53.451Z